Print

Print


Sorry to repoprt there is no progress. Amgen is standing firm in their
denial of treatment for the GDNF trial participants.

See: http://www.pdpipeline.org/focus_updates.htm

to read what the University of Kentucky and Bristol, United Kingdom trial
doctors have to say about how their patients improved while receiving
GDNF treatments and why they want Amgen to reinstate treatment. There is
also a video of the British patients before and after treatment.

We must tell Amgen that the Parkinson's community is standing behind
these patients and we will not tolerate their unethical treatment of
these courageous men and women who risked their lives to further the
research . The Parkinson's Disease Foundation, Parkinson's Action
Network, Dr. Abraham Lieberman, Dr. Donald Gash, and many other prominent
Parkinson's researchers are speaking out against Amgen's treatment of the
trial participants. The company's justifications for halting the trial
and then denying further treatment -- their claims about a "placebo
effect" and about safety issues --  are being challenged .

You won't be able to read about this in your local newspaper -- most of
the media is only parroting Amgen's press release.  However you can find
the trial patients' and doctors' viewpoints on PD advocates' web sites
such as the Parkinson Pipeline Project
<http://www.pdpipeline.org/focus_updates.htm>  and  the Grassroots
Connection
<http://www.grassrootsconnection.com/grcissue_GDNF_research.htm>

This is the true beauty of the Internet.

Please support your fellow parkinson's patients. See what you can do to
encourage Amgen to reverse its decision and allow reinstatement of GDNF
for the trial participants at
http://pdpipeline.org/whatucando.htm

Thanks,
Linda

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn